EODData

FRA, PHPN: Galectin Therapeutics Inc

12 Jan 2026
LAST:

2.540

CHANGE:
 0.02
OPEN:
2.660
HIGH:
2.660
ASK:
0.000
VOLUME:
78
CHG(%):
0.78
PREV:
2.560
LOW:
2.540
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Jan 262.6602.6602.5402.54078
09 Jan 262.7202.7202.5602.560290
08 Jan 262.9802.9802.6002.600290
07 Jan 262.9203.0402.9002.900290
06 Jan 263.2603.2602.8202.8200
05 Jan 263.4203.4203.1603.16078
02 Jan 263.5003.5003.2803.28078
30 Dec 253.4203.4203.4003.40078
29 Dec 253.4003.4003.3203.32078

PROFILE

Name:Galectin Therapeutics Inc
About:Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Sector:Healthcare
Industry:Biotechnology
Address:4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071
Website:https://galectintherapeutics.com
ISIN:US3632252025
LEI:5299004HFYSAZM2ALW85

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-4.29 
Forward P/E:-4.66 
PEG Ratio:0.15 
Price to Book:-1.67 
Return on Assets:-0.87 
Return on Equity:0.46 
Shares:64.06M 
Market Cap:162.71M 

TECHNICAL INDICATORS

MA5:2.685.7%
MA10:2.9817.5%
MA20:3.9756.3%
MA50:4.3872.6%
MA100:4.0961.1%
MA200:2.8813.3%
RSI14:11.83 
WPR14:-100.00 
MTM14:-2.91
ROC14:-0.53 
ATR:0.35 
Week High:3.4234.6%
Week Low:2.540.0%
Month High:5.80128.3%
Month Low:2.5413.3%
Year High:5.80128.3%
Year Low:1.05141.9%
Volatility:137.21 

RECENT SPLITS

Date Ratio
23 Mar 20121-6